Kinnate Biopharma Financial Health

Short Term Liabilities: KNTE's short term assets ($261.2M) exceed its short term liabilities ($15.3M).

Long Term Liabilities: KNTE's short term assets ($261.2M) exceed its long term liabilities ($3.4M).

Debt Level: KNTE is debt free.

Reducing Debt: KNTE has not had any debt for past 5 years.

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: KNTE has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: KNTE has sufficient cash runway for 1.9 years if free cash flow continues to reduce at historical rates of 51.4% each year.

• Healthy companies in the Pharmaceuticals & Biotech industry.